Come up with a name for your new list and we'll add to it:
Jennewein Biotechnologie raised a round of funding on July 25, 2018. Investors include
European Investment Bank.
Jennewein Biotechnologie is a Rheinbreitbach, Germany-based industrial biotechnology company that manufactures a portfolio of HMO products, such as 2'-fucosyllactose, 3'-fucosyllactose and lacto-N-tet…